CPC Exam Dumps - Certified Professional Coder (CPC) Exam

69209 = Cerumen removal using irrigation

69210 = Cerumen removal using instrumentation

Different techniques on different ears require separate codes with laterality modifiers

1. Procedure and CPT® Code Selection:

The patient underwent venous thrombosis imaging of each leg to assess for deep venous thrombosis (DVT).

CPT® Code 78457 is used for a venous thrombosis imaging study. This code is appropriate for imaging to detect DVT.

Modifier 50 is applied to indicate a bilateral procedure, as imaging was performed on both legs.

2. Diagnosis and ICD-10-CM Code Selection:

ICD-10-CM Code I82.403 is used for acute embolism and thrombosis of unspecified deep veins of bilateral lower extremities. This code accurately describes the finding of DVT in both legs.

Other ICD-10-CM options, such as I82.401 and I82.402, specify unilateral lower extremity involvement, which does not accurately reflect the bilateral findings in this case.

3. Rationale for Excluding Other Options:

Code 78458 (in options A and D) is for a more comprehensive study, often cardiac or whole-body blood pool imaging, and is not specific to leg venous thrombosis.

Option C, which lists 78457 with individual RT and LT modifiers, is incorrect as Modifier 50 is appropriate for bilateral imaging on both legs.

4. AAPC and CPT® Coding Guidelines:

According to AAPC and CPT® guidelines, 78457 with Modifier 50 should be used for bilateral venous imaging studies, and I82.403 correctly captures bilateral DVT.

Thus, the correct answer is B. 78457-50, I82.403.

1. Procedure and CPT® Code Selection:

The patient underwent a suppression study involving five glucose tests and five human growth hormone tests.

CPT® Code 80430 represents a suppression panel specifically for growth hormone studies, which includes various assessments for diagnosing abnormal growth.

CPT® Code 82947 is used for each glucose test performed, and since five glucose tests were conducted, it should be coded as 82947 x 5.

CPT® Code 83003 is used for each human growth hormone test performed, and since five tests were conducted, it should be coded as 83003 x 5.

2. Rationale for Excluding Other Options:

Option A lists 82947 x 2 and 83003 without sufficient units to account for the five tests each, which does not match the actual number of tests performed.

Option B omits the suppression panel code 80430, which is necessary for documenting the overall suppression study.

Option D does not provide the correct quantity of glucose and growth hormone tests, which were each performed five times.

3. AAPC and CPT® Coding Guidelines:

According to AAPC guidelines, when a suppression panel includes multiple components that are performed more than once, the specific panel code 80430 should be used along with the correct number of individual component codes.

Therefore, the correct answer is C. 80430, 82947 x 5, 83003 x 5.

1. CPT® Code 11604: This code is used for the excision of a malignant lesion on the back, with a size of 3.5 cm including margins. The 11600 series covers excision of malignant skin lesions, with 11604 being the correct code for a lesion size over 3.0 cm but not exceeding 4.0 cm.

2. CPT® Code 17110: This code is appropriate for the destruction of a benign lesion on the face (right cheek) via cryosurgery. 17110 covers the destruction of benign lesions (up to 14 lesions).

3. ICD-10-CM Code C44.509: This code represents unspecified malignant neoplasm of skin of trunk (back).

4. ICD-10-CM Code D23.39: This code is used for a benign neoplasm of skin of other parts of the face (right cheek).

Explanation of other options:

A. 11604, 11442, C76.8, C76.0: Incorrect because 11442 is for excision of a benign lesion, not a malignant lesion.

B. 11404, 11442, C44.509, D23.39: Incorrect because 11404 is used for a benign lesion excision, not malignant.

D. 11604, 11642, C76.8, C76.0: Incorrect as 11642 would indicate a second malignant excision rather than the benign lesion destruction.

Thus, the correct answer is C. 11604, 17110, C44.509, D23.39.

C2617 – Sinus implant, drug-eluting

Described implant:

Ethmoid sinus

Drug-eluting (corticosteroid)

Absorbable

Why others are incorrect:

C1877 – Vascular stent

S1091 – Temporary code

C9600 – Coronary intervention

1. Procedure and CPT® Code Selection:

The test performed is a quantitative, high-sensitive fluorescent enzyme immunoassay to measure specific IgE for recombinant peanut components.

CPT® Code 86008 is specific for allergen-specific IgE testing for recombinant or component-resolved allergens. This code is appropriate for testing IgE response to individual allergenic components, such as those found in peanuts.

2. Rationale for Excluding Other Options:

Code 86003 is used for allergen-specific IgE testing but does not apply to recombinant or component-resolved allergens, which are covered by 86008.

Code 86001 is for total IgE testing and does not measure specific allergens.

Code 86005 is for a general allergy screening (not specific IgE or component testing) and is not appropriate for component-resolved peanut allergen testing.

3. AAPC and CPT® Coding Guidelines:

According to AAPC guidelines, 86008 should be used for specific IgE testing related to recombinant allergens or component testing.

Therefore, the correct answer is C. 86008.

99152 – Moderate sedation, same physician, patient under 5 years, initial 15 minutes

Time documented: 21 minutes

First 15 minutes = 99152

Additional 15 minutes (99153) not reported separately in CPT® exam context

Why others are incorrect:

99151 – Minimal sedation

99155 / 99156 – Different age/provider scenarios